Hepatitis C infection in HIV-1 natural viral suppressors
HIV-1 natural viral suppressors (NVSs) demonstrate an intrinsic ability to control HIV-1 replication in the absence of antiretroviral therapy. The objective of this study was to investigate whether HIV-infected NVSs also demonstrate enhanced ability to control hepatitis C virus (HCV) infection, and...
Gespeichert in:
| Veröffentlicht in: | AIDS (London) 2010-07, Vol.24 (11), p.1689-1695 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1695 |
|---|---|
| container_issue | 11 |
| container_start_page | 1689 |
| container_title | AIDS (London) |
| container_volume | 24 |
| creator | SAJADI, Mohammad M SHAKERI, Nahzinine TALWANI, Rohit REDFIELD, Robert R |
| description | HIV-1 natural viral suppressors (NVSs) demonstrate an intrinsic ability to control HIV-1 replication in the absence of antiretroviral therapy. The objective of this study was to investigate whether HIV-infected NVSs also demonstrate enhanced ability to control hepatitis C virus (HCV) infection, and whether HCV infection in the NVSs affects the degree of HIV control.
A cross-sectional study was undertaken to compare HCV-related parameters in the NVS to the two race-matched cohorts (HIV/HCV-coinfected or HCV-monoinfected patients). Within the NVS, HIV-related parameters were compared based on the presence or absence of chronic HCV.
NVS patients had a significantly higher clearance rate of HCV at 23.3% (seven of 30), compared to the 6.5% (23 of 350) of HIV/HCV-coinfected and 9.1% (32 of 350) of HCV-monoinfected patients (P = 0.005 and P = 0.024, respectively). Apart from the HCV clearance rate, there was no significant difference in HCV-related parameters such as HCV viral load or liver histology in the NVS with chronic HCV compared to HCV/HIV-coinfected patients or HCV-monoinfected patients. However, NVS patients with chronic HCV infection had statistically significant lower CD4 cell count and CD4%, and lower CD4/CD8 ratio compared to those NVSs without chronic HCV infection (P = 0.029, P = 0.046, and P = 0.062, respectively).
It appears that some NVS patients have the ability to effectively control multiple agents that can cause chronic viral infections. In addition, it appears that the presence of chronic HCV infection within the NVS adversely affects immunological parameters. |
| doi_str_mv | 10.1097/QAD.0b013e32833a2a32 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2894991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733309782</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-6105e0ba66194cd8cfd2e44e8b33d3ea130f4e9189ec050670c24a9b75c39d553</originalsourceid><addsrcrecordid>eNqFkU9rFTEUxYMo9rX6DURmI66m3uQmmWQjlGfbVyiIoG5DJnNHI_NmxmSm4LdvSp_1z6abJHB_53BuDmOvOJxysM27T2cfTqEFjoTCIHrhUTxhGy4brJVq-FO2AaFtbbGBI3ac8w8AUGDMc3YkQOpGWNgws6PZL3GJudpWcewpLHEay6vaXX2teTX6ZU1-qG7i3ZnXeU6U85TyC_as90Oml4f7hH25OP-83dXXHy-vtmfXdZDaLrXmoAharzW3MnQm9J0gKcm0iB2S5wi9JMuNpVDS6QaCkN62jQpoO6XwhL2_953Xdk9doHEpSdyc4t6nX27y0f07GeN39226ccJYaS0vBm8PBmn6uVJe3D7mQMPgR5rW7BolFUqt4XESEcvPG1FIeU-GNOWcqH_Iw8HdteNKO-7_dors9d-7PIh-11GANwfA5-CHPvkxxPyHQxCAJe4ta46YQw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733309782</pqid></control><display><type>article</type><title>Hepatitis C infection in HIV-1 natural viral suppressors</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SAJADI, Mohammad M ; SHAKERI, Nahzinine ; TALWANI, Rohit ; REDFIELD, Robert R</creator><creatorcontrib>SAJADI, Mohammad M ; SHAKERI, Nahzinine ; TALWANI, Rohit ; REDFIELD, Robert R</creatorcontrib><description>HIV-1 natural viral suppressors (NVSs) demonstrate an intrinsic ability to control HIV-1 replication in the absence of antiretroviral therapy. The objective of this study was to investigate whether HIV-infected NVSs also demonstrate enhanced ability to control hepatitis C virus (HCV) infection, and whether HCV infection in the NVSs affects the degree of HIV control.
A cross-sectional study was undertaken to compare HCV-related parameters in the NVS to the two race-matched cohorts (HIV/HCV-coinfected or HCV-monoinfected patients). Within the NVS, HIV-related parameters were compared based on the presence or absence of chronic HCV.
NVS patients had a significantly higher clearance rate of HCV at 23.3% (seven of 30), compared to the 6.5% (23 of 350) of HIV/HCV-coinfected and 9.1% (32 of 350) of HCV-monoinfected patients (P = 0.005 and P = 0.024, respectively). Apart from the HCV clearance rate, there was no significant difference in HCV-related parameters such as HCV viral load or liver histology in the NVS with chronic HCV compared to HCV/HIV-coinfected patients or HCV-monoinfected patients. However, NVS patients with chronic HCV infection had statistically significant lower CD4 cell count and CD4%, and lower CD4/CD8 ratio compared to those NVSs without chronic HCV infection (P = 0.029, P = 0.046, and P = 0.062, respectively).
It appears that some NVS patients have the ability to effectively control multiple agents that can cause chronic viral infections. In addition, it appears that the presence of chronic HCV infection within the NVS adversely affects immunological parameters.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0b013e32833a2a32</identifier><identifier>PMID: 20467290</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>AIDS/HIV ; Biological and medical sciences ; CD4 Lymphocyte Count ; Cohort Studies ; Cross-Sectional Studies ; Female ; Hepacivirus - isolation & purification ; Hepacivirus - physiology ; Hepatitis C - complications ; Hepatitis C - immunology ; Hepatitis C - virology ; Hepatitis C virus ; Hepatitis C, Chronic - complications ; Hepatitis C, Chronic - immunology ; Hepatitis C, Chronic - virology ; HIV Infections - complications ; HIV Infections - immunology ; HIV Infections - virology ; HIV Long-Term Survivors ; HIV-1 - isolation & purification ; HIV-1 - physiology ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral hepatitis ; Viral Load ; Virus Replication</subject><ispartof>AIDS (London), 2010-07, Vol.24 (11), p.1689-1695</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-6105e0ba66194cd8cfd2e44e8b33d3ea130f4e9189ec050670c24a9b75c39d553</citedby><cites>FETCH-LOGICAL-c469t-6105e0ba66194cd8cfd2e44e8b33d3ea130f4e9189ec050670c24a9b75c39d553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23020345$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20467290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SAJADI, Mohammad M</creatorcontrib><creatorcontrib>SHAKERI, Nahzinine</creatorcontrib><creatorcontrib>TALWANI, Rohit</creatorcontrib><creatorcontrib>REDFIELD, Robert R</creatorcontrib><title>Hepatitis C infection in HIV-1 natural viral suppressors</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>HIV-1 natural viral suppressors (NVSs) demonstrate an intrinsic ability to control HIV-1 replication in the absence of antiretroviral therapy. The objective of this study was to investigate whether HIV-infected NVSs also demonstrate enhanced ability to control hepatitis C virus (HCV) infection, and whether HCV infection in the NVSs affects the degree of HIV control.
A cross-sectional study was undertaken to compare HCV-related parameters in the NVS to the two race-matched cohorts (HIV/HCV-coinfected or HCV-monoinfected patients). Within the NVS, HIV-related parameters were compared based on the presence or absence of chronic HCV.
NVS patients had a significantly higher clearance rate of HCV at 23.3% (seven of 30), compared to the 6.5% (23 of 350) of HIV/HCV-coinfected and 9.1% (32 of 350) of HCV-monoinfected patients (P = 0.005 and P = 0.024, respectively). Apart from the HCV clearance rate, there was no significant difference in HCV-related parameters such as HCV viral load or liver histology in the NVS with chronic HCV compared to HCV/HIV-coinfected patients or HCV-monoinfected patients. However, NVS patients with chronic HCV infection had statistically significant lower CD4 cell count and CD4%, and lower CD4/CD8 ratio compared to those NVSs without chronic HCV infection (P = 0.029, P = 0.046, and P = 0.062, respectively).
It appears that some NVS patients have the ability to effectively control multiple agents that can cause chronic viral infections. In addition, it appears that the presence of chronic HCV infection within the NVS adversely affects immunological parameters.</description><subject>AIDS/HIV</subject><subject>Biological and medical sciences</subject><subject>CD4 Lymphocyte Count</subject><subject>Cohort Studies</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Hepacivirus - isolation & purification</subject><subject>Hepacivirus - physiology</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - immunology</subject><subject>Hepatitis C - virology</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - complications</subject><subject>Hepatitis C, Chronic - immunology</subject><subject>Hepatitis C, Chronic - virology</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV Long-Term Survivors</subject><subject>HIV-1 - isolation & purification</subject><subject>HIV-1 - physiology</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral hepatitis</subject><subject>Viral Load</subject><subject>Virus Replication</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9rFTEUxYMo9rX6DURmI66m3uQmmWQjlGfbVyiIoG5DJnNHI_NmxmSm4LdvSp_1z6abJHB_53BuDmOvOJxysM27T2cfTqEFjoTCIHrhUTxhGy4brJVq-FO2AaFtbbGBI3ac8w8AUGDMc3YkQOpGWNgws6PZL3GJudpWcewpLHEay6vaXX2teTX6ZU1-qG7i3ZnXeU6U85TyC_as90Oml4f7hH25OP-83dXXHy-vtmfXdZDaLrXmoAharzW3MnQm9J0gKcm0iB2S5wi9JMuNpVDS6QaCkN62jQpoO6XwhL2_953Xdk9doHEpSdyc4t6nX27y0f07GeN39226ccJYaS0vBm8PBmn6uVJe3D7mQMPgR5rW7BolFUqt4XESEcvPG1FIeU-GNOWcqH_Iw8HdteNKO-7_dors9d-7PIh-11GANwfA5-CHPvkxxPyHQxCAJe4ta46YQw</recordid><startdate>20100717</startdate><enddate>20100717</enddate><creator>SAJADI, Mohammad M</creator><creator>SHAKERI, Nahzinine</creator><creator>TALWANI, Rohit</creator><creator>REDFIELD, Robert R</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20100717</creationdate><title>Hepatitis C infection in HIV-1 natural viral suppressors</title><author>SAJADI, Mohammad M ; SHAKERI, Nahzinine ; TALWANI, Rohit ; REDFIELD, Robert R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-6105e0ba66194cd8cfd2e44e8b33d3ea130f4e9189ec050670c24a9b75c39d553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>AIDS/HIV</topic><topic>Biological and medical sciences</topic><topic>CD4 Lymphocyte Count</topic><topic>Cohort Studies</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Hepacivirus - isolation & purification</topic><topic>Hepacivirus - physiology</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - immunology</topic><topic>Hepatitis C - virology</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - complications</topic><topic>Hepatitis C, Chronic - immunology</topic><topic>Hepatitis C, Chronic - virology</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV Long-Term Survivors</topic><topic>HIV-1 - isolation & purification</topic><topic>HIV-1 - physiology</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral hepatitis</topic><topic>Viral Load</topic><topic>Virus Replication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SAJADI, Mohammad M</creatorcontrib><creatorcontrib>SHAKERI, Nahzinine</creatorcontrib><creatorcontrib>TALWANI, Rohit</creatorcontrib><creatorcontrib>REDFIELD, Robert R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SAJADI, Mohammad M</au><au>SHAKERI, Nahzinine</au><au>TALWANI, Rohit</au><au>REDFIELD, Robert R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis C infection in HIV-1 natural viral suppressors</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2010-07-17</date><risdate>2010</risdate><volume>24</volume><issue>11</issue><spage>1689</spage><epage>1695</epage><pages>1689-1695</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>HIV-1 natural viral suppressors (NVSs) demonstrate an intrinsic ability to control HIV-1 replication in the absence of antiretroviral therapy. The objective of this study was to investigate whether HIV-infected NVSs also demonstrate enhanced ability to control hepatitis C virus (HCV) infection, and whether HCV infection in the NVSs affects the degree of HIV control.
A cross-sectional study was undertaken to compare HCV-related parameters in the NVS to the two race-matched cohorts (HIV/HCV-coinfected or HCV-monoinfected patients). Within the NVS, HIV-related parameters were compared based on the presence or absence of chronic HCV.
NVS patients had a significantly higher clearance rate of HCV at 23.3% (seven of 30), compared to the 6.5% (23 of 350) of HIV/HCV-coinfected and 9.1% (32 of 350) of HCV-monoinfected patients (P = 0.005 and P = 0.024, respectively). Apart from the HCV clearance rate, there was no significant difference in HCV-related parameters such as HCV viral load or liver histology in the NVS with chronic HCV compared to HCV/HIV-coinfected patients or HCV-monoinfected patients. However, NVS patients with chronic HCV infection had statistically significant lower CD4 cell count and CD4%, and lower CD4/CD8 ratio compared to those NVSs without chronic HCV infection (P = 0.029, P = 0.046, and P = 0.062, respectively).
It appears that some NVS patients have the ability to effectively control multiple agents that can cause chronic viral infections. In addition, it appears that the presence of chronic HCV infection within the NVS adversely affects immunological parameters.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>20467290</pmid><doi>10.1097/QAD.0b013e32833a2a32</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-9370 |
| ispartof | AIDS (London), 2010-07, Vol.24 (11), p.1689-1695 |
| issn | 0269-9370 1473-5571 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2894991 |
| source | MEDLINE; Journals@Ovid Ovid Autoload; EZB-FREE-00999 freely available EZB journals |
| subjects | AIDS/HIV Biological and medical sciences CD4 Lymphocyte Count Cohort Studies Cross-Sectional Studies Female Hepacivirus - isolation & purification Hepacivirus - physiology Hepatitis C - complications Hepatitis C - immunology Hepatitis C - virology Hepatitis C virus Hepatitis C, Chronic - complications Hepatitis C, Chronic - immunology Hepatitis C, Chronic - virology HIV Infections - complications HIV Infections - immunology HIV Infections - virology HIV Long-Term Survivors HIV-1 - isolation & purification HIV-1 - physiology Human immunodeficiency virus 1 Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Male Medical sciences Middle Aged Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis Viral Load Virus Replication |
| title | Hepatitis C infection in HIV-1 natural viral suppressors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A30%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20C%20infection%20in%20HIV-1%20natural%20viral%20suppressors&rft.jtitle=AIDS%20(London)&rft.au=SAJADI,%20Mohammad%20M&rft.date=2010-07-17&rft.volume=24&rft.issue=11&rft.spage=1689&rft.epage=1695&rft.pages=1689-1695&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0b013e32833a2a32&rft_dat=%3Cproquest_pubme%3E733309782%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733309782&rft_id=info:pmid/20467290&rfr_iscdi=true |